Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Nicotinic Acid Accelerates HDL Cholesteryl Ester Turnover in Obese Insulin-Resistant Dogs.

Le Bloc'h J, Leray V, Nazih H, Gauthier O, Serisier S, Magot T, Krempf M, Nguyen P, Ouguerram K.

PLoS One. 2015 Sep 14;10(9):e0136934. doi: 10.1371/journal.pone.0136934. eCollection 2015.

2.

Low rate of production of apolipoproteins B100 and AI in 2 patients with Anderson disease (chylomicron retention disease).

Ouguerram K, Zaïr Y, Kasbi-Chadli F, Nazih H, Bligny D, Schmitz J, Aparicio T, Chétiveaux M, Magot T, Aggerbeck LP, Samson-Bouma ME, Krempf M.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1520-5. doi: 10.1161/ATVBAHA.112.245076. Epub 2012 Mar 22.

PMID:
22441101
3.

Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters.

Tréguier M, Briand F, Boubacar A, André A, Magot T, Nguyen P, Krempf M, Sulpice T, Ouguerram K.

Eur J Clin Invest. 2011 Sep;41(9):921-8. doi: 10.1111/j.1365-2362.2011.02478.x. Epub 2011 Feb 8.

PMID:
21299553
4.

Nicotinic acid decreases apolipoprotein B100-containing lipoprotein levels by reducing hepatic very low density lipoprotein secretion through a possible diacylglycerol acyltransferase 2 inhibition in obese dogs.

Le Bloc'h J, Leray V, Chetiveaux M, Freuchet B, Magot T, Krempf M, Nguyen P, Ouguerram K.

J Pharmacol Exp Ther. 2010 Aug;334(2):583-9. doi: 10.1124/jpet.110.167478. Epub 2010 May 4.

PMID:
20442223
5.

Disturbance of apolipoprotein B100 containing lipoprotein metabolism in severe hyperlipidemic and lipodystrophic HIV patients on combined antiretroviral therapy: evidences of insulin resistance effect.

Ouguerram K, Zair Y, Billon S, Chétiveaux M, Brunet-François C, Ngohou-Bach K, Allavena C, Reliquet V, Milpied B, Magot T, Raffi F, Krempf M.

Med Chem. 2008 Nov;4(6):544-50.

PMID:
18991738
6.

Hypertriglyceridaemic insulin-resistant obese dog model: effects of high-fat diet depending on age.

Serisier S, Gayet C, Leray V, Le Bloc'h J, Ouguerram K, Magot T, Nguyen P.

J Anim Physiol Anim Nutr (Berl). 2008 Aug;92(4):419-25. doi: 10.1111/j.1439-0396.2007.00785.x. Epub 2008 Mar 13.

PMID:
18662350
7.

The hyperenergetic-fed obese dog, a model of disturbance of apolipoprotein B-100 metabolism associated with insulin resistance: kinetic study using stable isotopes.

Briand F, Bailhache E, Andre A, Magot T, Krempf M, Nguyen P, Ouguerram K.

Metabolism. 2008 Jul;57(7):966-72. doi: 10.1016/j.metabol.2008.02.013.

PMID:
18555839
8.

Effects of green tea on insulin sensitivity, lipid profile and expression of PPARalpha and PPARgamma and their target genes in obese dogs.

Serisier S, Leray V, Poudroux W, Magot T, Ouguerram K, Nguyen P.

Br J Nutr. 2008 Jun;99(6):1208-16. Epub 2007 Dec 6.

PMID:
18053305
9.

Metabolism of high density lipoprotein apolipoprotein A-I and cholesteryl ester in insulin resistant dog: a stable isotope study.

Briand F, Bailhache E, Nguyen P, Krempf M, Magot T, Ouguerram K.

Diabetes Obes Metab. 2007 Jan;9(1):139-42.

PMID:
17199733
10.

Effect of n-3 fatty acids on metabolism of apoB100-containing lipoprotein in type 2 diabetic subjects.

Ouguerram K, Maugeais C, Gardette J, Magot T, Krempf M.

Br J Nutr. 2006 Jul;96(1):100-6.

PMID:
16869997
11.

Fenofibrate lowers lipid parameters in obese dogs.

Serisier S, Briand F, Ouguerram K, Siliart B, Magot T, Nguyen P.

J Nutr. 2006 Jul;136(7 Suppl):2037S-2040S. doi: 10.1093/jn/136.7.2037S. No abstract available.

PMID:
16772490
12.

Atorvastatin increases intestinal cholesterol absorption in dogs.

Briand F, Serisier S, Krempf M, Siliart B, Magot T, Ouguerram K, Nguyen P.

J Nutr. 2006 Jul;136(7 Suppl):2034S-2036S. doi: 10.1093/jn/136.7.2034S. No abstract available.

PMID:
16772489
13.

Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs.

Briand F, Magot T, Krempf M, Nguyen P, Ouguerram K.

Eur J Clin Invest. 2006 Apr;36(4):224-30. Erratum in: Eur J Clin Invest. 2006 Jul;36(7):518.

PMID:
16620283
14.

Selective uptake of high density lipoproteins cholesteryl ester in the dog, a species lacking in cholesteryl ester transfer protein activity; An in vivo approach using stable isotopes.

Ouguerram K, Nguyen P, Krempf M, Pouteau E, Briand F, Bailhache E, Magot T.

Comp Biochem Physiol B Biochem Mol Biol. 2004 Aug;138(4):339-45.

PMID:
15325333
15.

Metabolism of cholesterol ester of apolipoprotein B100-containing lipoproteins in dogs: evidence for disregarding cholesterol ester transfer.

Bailhache E, Briand F, Nguyen P, Krempf M, Magot T, Ouguerram K.

Eur J Clin Invest. 2004 Aug;34(8):527-34.

PMID:
15305886
16.

Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9.

Ouguerram K, Chetiveaux M, Zair Y, Costet P, Abifadel M, Varret M, Boileau C, Magot T, Krempf M.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1448-53. Epub 2004 May 27.

PMID:
15166014
17.

An insulin-resistant hypertriglyceridaemic normotensive obese dog model: assessment of insulin resistance by the euglycaemic hyperinsulinaemic clamp in combination with the stable isotope technique.

Bailhache E, Ouguerram K, Gayet C, Krempf M, Siliart B, Magot T, Nguyen P.

J Anim Physiol Anim Nutr (Berl). 2003 Apr;87(3-4):86-95.

PMID:
14511132
18.

Lipoproteins abnormalities in obese insulin-resistant dogs.

Bailhache E, Nguyen P, Krempf M, Siliart B, Magot T, Ouguerram K.

Metabolism. 2003 May;52(5):559-64.

PMID:
12759884
19.

Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.

Ouguerram K, Magot T, Zaïr Y, Marchini JS, Charbonnel B, Laouenan H, Krempf M.

J Pharmacol Exp Ther. 2003 Jul;306(1):332-7. Epub 2003 Apr 8.

PMID:
12684543
20.

A new labeling approach using stable isotopes to study in vivo plasma cholesterol metabolism in humans.

Ouguerram K, Krempf M, Maugeais C, Maugère P, Darmaun D, Magot T.

Metabolism. 2002 Jan;51(1):5-11.

PMID:
11782865
21.

Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus.

Frénais R, Ouguerram K, Maugeais C, Mahot P, Charbonnel B, Magot T, Krempf M.

Atherosclerosis. 2001 Jul;157(1):131-5.

PMID:
11427212
22.

Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia.

Frénais R, Maugeais C, Ouguerram K, Zaïr Y, Bard JM, Charbonnel B, Magot T, Krempf M.

Metabolism. 2001 Jun;50(6):635-9.

PMID:
11398137
23.

In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus.

Frénais R, Nazih H, Ouguerram K, Maugeais C, Zaïr Y, Bard JM, Charbonnel B, Magot T, Krempf M.

J Clin Endocrinol Metab. 2001 May;86(5):1962-7.

PMID:
11344192
24.

Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.

Maugeais C, Ouguerram K, Frénais R, Maugère P, Charbonnel B, Magot T, Krempf M.

J Clin Endocrinol Metab. 2001 Apr;86(4):1679-86.

PMID:
11297603
25.

Effects of F2833 on cholesterol metabolism in the genetically hyperlipidemic rat.

Ouguerram K, Lutton C, Delhon A, Magot T.

Eur J Pharmacol. 2001 Mar;415(2-3):293-9.

PMID:
11275012
26.

Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: a stable isotope study.

Frénais R, Ouguerram K, Maugeais C, Marchini JS, Benlian P, Bard JM, Magot T, Krempf M.

J Lipid Res. 1999 Aug;40(8):1506-11.

27.

Kinetic study of apo B100 containing lipoprotein metabolism using amino acids labeled with stable isotopes: methodological aspects.

Maugeais C, Ouguerram K, Krempf M, Magot T.

Clin Chem Lab Med. 1998 Oct;36(10):739-45. Review.

PMID:
9853798
28.

Lipoprotein kinetics in patients with analbuminemia. Evidence for the role of serum albumin in controlling lipoprotein metabolism.

Maugeais C, Braschi S, Ouguerram K, Maugeais P, Mahot P, Jacotot B, Darmaun D, Magot T, Krempf M.

Arterioscler Thromb Vasc Biol. 1997 Jul;17(7):1369-75.

PMID:
9261269
29.

High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study.

Frénais R, Ouguerram K, Maugeais C, Mahot P, Maugère P, Krempf M, Magot T.

Diabetologia. 1997 May;40(5):578-83.

PMID:
9165227
30.

A minimal model using stable isotopes to study the metabolism of apolipoprotein B-containing lipoproteins in humans.

Maugeais C, Ouguerram K, Krempf M, Maugeais P, Gardette J, Bigot E, Magot T.

Diabetes Metab. 1996 Feb;22(1):57-63.

PMID:
8697297
31.

Metabolism of plasma lipoproteins in the genetically hypercholesterolemic rat (RICO).

Ouguerram K, Magot T, Lutton C.

Metabolism. 1996 Jan;45(1):4-11.

PMID:
8544775
32.

Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis.

Poupon RE, Ouguerram K, Chrétien Y, Verneau C, Eschwège E, Magot T, Poupon R.

Hepatology. 1993 Apr;17(4):577-82.

PMID:
8477962
33.

Overestimation of the lipoprotein fractional catabolic rate (FCR) measured in short duration experiments.

Champarnaud G, Ouguerram K, Magot T, Lutton C.

J Pharmacobiodyn. 1992 Sep;15(9):541-6.

PMID:
1287188
34.

Metabolism of intestinal triglyceride-rich lipoproteins in the genetically hypercholesterolemic rat (RICO)

Ouguerram K, Magot T, Lutton C.

Atherosclerosis. 1992 Apr;93(3):201-8. Erratum in: Atherosclerosis 1992 Aug;95(2-3):249.

PMID:
1590825
35.

In vivo effect of simvastatin on lipoprotein cholesteryl ester metabolism in normocholesterolemic volunteers.

Magot T, Malmendier CL, Ouguerram K, Lontie JF, Lutton C.

Clin Chim Acta. 1991 Jan 31;196(1):59-68.

PMID:
2022059
36.

Origin of cholesterol and bile acids in the diverted bile of two patients with total small bowel resection.

Férézou J, Beau P, Parquet M, Hajri T, Magot T, Matuchansky C, Lutton C.

Adv Exp Med Biol. 1991;285:183-7. No abstract available.

PMID:
1907080
37.

Alterations in cholesterol metabolism in the genetically hypercholesterolemic RICO rat: an overview.

Ouguerram K, Magot T, Lutton C.

Adv Exp Med Biol. 1991;285:257-74. Review. No abstract available.

PMID:
1858555
38.
39.

Critical analysis of the use of 14C-acetate for measuring in vivo rat cholesterol synthesis.

Lutton C, Ferezou J, Sérougne C, Verneau C, Champarnaud G, Magot T, Mathe D, Sulpice JC.

Reprod Nutr Dev. 1990;30(1):71-84.

PMID:
2331308
40.

Effect of simvastatin on receptor-dependent low density lipoprotein catabolism in normocholesterolemic human volunteers.

Malmendier CL, Lontie JF, Delcroix C, Magot T.

Atherosclerosis. 1989 Dec;80(2):101-9.

PMID:
2610723
41.
42.

In vivo metabolism of apolipoproteins C-II and C-III in normal and hypertriglyceridemic subjects.

Malmendier CL, Lontie JF, Dubois D, Delcroix C, Magot T, De Roy L.

Adv Exp Med Biol. 1988;243:299-309. No abstract available.

PMID:
3223423
43.

A multicompartmental model of cholesterol metabolism in rats.

Magot T.

J Physiol (Paris). 1988-1989;83(2):80-94. Review.

PMID:
3074997
44.

Origin and fate of rat plasma cholesterol in vivo. Modelling of cholesterol movements between plasma and organs.

Magot T, Frein Y, Champarnaud G, Cheruy A, Lutton C.

Biochim Biophys Acta. 1987 Oct 17;921(3):587-94.

PMID:
3663698
45.

A microcomputer program for simulation of linear compartmental physiological models: computation on Apple IIe.

Champarnaud G, Magot T, Lutton C.

Comput Methods Programs Biomed. 1987 Feb;24(1):63-4.

PMID:
3829650
46.

The measurement in vivo of the rate of unesterified cholesterol exchange between rat plasma and erythrocytes.

Magot T, Frein Y, Giraud F, Cheruy A.

Biochim Biophys Acta. 1985 May 17;834(3):331-5.

PMID:
3995070
47.

Development of a program package for modelling biochemical systems.

Anfreville R, Champarnaud G, Magot T.

Int J Biomed Comput. 1985 May;16(3-4):245-56.

PMID:
3839210
49.

Origin and fate of cholesterol in rat plasma lipoproteins in vivo. II. Modelling of cholesterol absorption and its release into plasma lipoproteins.

Magot T, Champarnaud G, Anfreville R, Lutton C, Chevallier F.

Ann Nutr Metab. 1985;29(3):160-74.

PMID:
4037724
50.

Origin and fate of cholesterol in rat plasma lipoproteins in vivo. I. Qualitative analysis.

Magot T, Verneau C, Lutton C, Chevallier F.

Ann Nutr Metab. 1985;29(3):147-59.

PMID:
4037723

Supplemental Content

Support Center